A systematic review and meta-analysis of preclinical studies showed that GLP-1RAs could improve the learning and memory abilities of AD rodents; in terms of pathology, GLP-1 Ras could reduce Aβ deposition and phosphorylated tau levels in the brains of AD rodents [216]. This evidence concerns the gene MAPT and Alzheimer disease.